Table 1 Participant characteristics
Characteristic* | All analyzable participants (n = 21) | Women taking 5 mg tamoxifen (n = 10) | Women taking 10 mg tamoxifen (n = 11) | p (5 mg vs. 10 mg) |
|---|---|---|---|---|
Mean age (SD, range) | 47.7 (4.1, 41–56) | 47.3 (4.4, 41–56) | 48.1 (4.0, 42–55) | 0.67 |
Mean body mass index (SD, range) | 26.5 (5.1, 19.5–42.4) | 26.1 (4.0, 20.7–34.8) | 26.8 (6.2, 19.5–42.4) | 0.75 |
Menopausal status** | > 0.99 | |||
Premenopausal | 14 (66) | 7 (70) | 7 (64) | |
Perimenopausal | 6 (29) | 3 (30) | 3 (27) | |
Postmenopausal | 1 (5) | 0 (0) | 1 (9) | |
BI-RADS mammographic density*** | 0.06 | |||
a | 0 (0) | 0 (0) | 0 (0) | |
b | 2 (10) | 1 (10) | 1 (9) | |
c | 12 (57) | 8 (80) | 4 (36) | |
d | 7 (33) | 1 (10) | 6 (55) | |
Gail model 5-year risk | > 0.99 | |||
< 1.67% | 15 (71) | 7 (70) | 8 (73) | |
≥ 1.67% | 6 (29) | 3 (30) | 3 (27) |